Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117345) titled 'A Randomized Controlled Trial of Brexpiprazole versus Aripiprazole in the Treatment of Major Depressive Disorder with Psychotic Symptoms in Adolescents' on Jan. 22.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Shandong mental health center
Condition:
Major Depressive Disorder with Psychotic Symptoms (MDD-PS)
Intervention:
Control group:Aripiprazole combined with Brexpiprazole analog and Escitalopram
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-02-01
Target Sample Size: Control group:40;Study group:40;
Countries of Recruitment:
China
To kn...